Latest News:
Subscribe to the latest in micro-cap news and podcasts, straight to your inbox.
Subscribe Now
Facebook Twitter Instagram Youtube

Featured News

Read More
About Hemp-Derived CBD
Cannabidiol (CBD) is one of at least 113 active cannabinoids identified in cannabis. It is a major phytocannabinoid, accounting for up to 40% of the plant’s extract.
Read More
Remedi – CBD Professionals you Can Trust
The team of Remedi is a collaboration project of hemp and CBD professionals.
Read More
Pressure BioSciences' New CBD Technology
Pressure Biosciences unveils new CBD beverage infusing technology
Watch Video

Hot Stocks of the Day

 
Hot Stocks of the Day by TradingView

Latest News

Q BioMed Inc. Joins Everett Jolly on the Stock Day Podcast (QBIO) December 10, 2019.
Radio Interviews 

Q BioMed Inc. Joins Everett Jolly on the Stock Day Podcast (QBIO) December 10, 2019.

Jesse Knittel Comments Off on Q BioMed Inc. Joins Everett Jolly on the Stock Day Podcast (QBIO) December 10, 2019.

About Q BioMed Inc. Q BioMed Inc. is a biotech acceleration and commercial stage company. We are focused on licensing

BioLargo’s CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide Through Third-Party Lab Testing
BioTech 

BioLargo’s CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide Through Third-Party Lab Testing

Jesse Knittel Comments Off on BioLargo’s CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide Through Third-Party Lab Testing
Applied BioSciences Outlines Key Value Driving Opportunities Expected in 2020 and Focus on Advancing BioPharma Pipeline with The Stock Day Podcast (APPB) December 10, 2019.
Radio Interviews 

Applied BioSciences Outlines Key Value Driving Opportunities Expected in 2020 and Focus on Advancing BioPharma Pipeline with The Stock Day Podcast (APPB) December 10, 2019.

Jesse Knittel Comments Off on Applied BioSciences Outlines Key Value Driving Opportunities Expected in 2020 and Focus on Advancing BioPharma Pipeline with The Stock Day Podcast (APPB) December 10, 2019.
ProMIS Neurosciences’ Alzheimer’s disease program takes on renewed significance following positive aducanumab news
BioTech 

ProMIS Neurosciences’ Alzheimer’s disease program takes on renewed significance following positive aducanumab news

Jesse Knittel Comments Off on ProMIS Neurosciences’ Alzheimer’s disease program takes on renewed significance following positive aducanumab news

Cannabis

James E. Wagner Cultivation Reports Fiscal Fourth Quarter and Full Year 2019 Financial Results
Cannabis 

James E. Wagner Cultivation Reports Fiscal Fourth Quarter and Full Year 2019 Financial Results

Jesse Knittel Comments Off on James E. Wagner Cultivation Reports Fiscal Fourth Quarter and Full Year 2019 Financial Results

KITCHENER, Ontario, Dec. 10, 2019 (GLOBE NEWSWIRE) — James E. Wagner Cultivation Corporation (“JWC” or the “Company”) (TSX VENTURE: JWCA;

Canbiola, Inc. Signs Contract to Acquire Green Grow Farms from Iconic Brands (CANB)
Cannabis 

Canbiola, Inc. Signs Contract to Acquire Green Grow Farms from Iconic Brands (CANB)

Jesse Knittel Comments Off on Canbiola, Inc. Signs Contract to Acquire Green Grow Farms from Iconic Brands (CANB)
Canbiola, Inc. Signs Contract to Acquire Green Grow Farms from Iconic Brands
Cannabis 

Canbiola, Inc. Signs Contract to Acquire Green Grow Farms from Iconic Brands

Jesse Knittel Comments Off on Canbiola, Inc. Signs Contract to Acquire Green Grow Farms from Iconic Brands
Global Canna Labs successfully exports Medical Cannabis from Jamaica to Canada for scientific purposes as its intended use
Cannabis 

Global Canna Labs successfully exports Medical Cannabis from Jamaica to Canada for scientific purposes as its intended use

Jesse Knittel Comments Off on Global Canna Labs successfully exports Medical Cannabis from Jamaica to Canada for scientific purposes as its intended use

Energy

IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market
Energy 

IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market

Jesse Knittel Comments Off on IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market

Aggressive Infill and Step-Out Program to Follow Up on High-Grade Uranium Discovery in Eastern Athabasca Basin; Spot U3O8 price has

UPDATE: NeoVolta Becomes First Lithium Iron Phosphate Energy Storage System Approved by California Energy Commission
Energy 

UPDATE: NeoVolta Becomes First Lithium Iron Phosphate Energy Storage System Approved by California Energy Commission

Jesse Knittel Comments Off on UPDATE: NeoVolta Becomes First Lithium Iron Phosphate Energy Storage System Approved by California Energy Commission
FuelCell Energy Inc. Announces New $200 Million Strategic Corporate Loan Facility with Orion Energy Partners
Energy 

FuelCell Energy Inc. Announces New $200 Million Strategic Corporate Loan Facility with Orion Energy Partners

Jesse Knittel Comments Off on FuelCell Energy Inc. Announces New $200 Million Strategic Corporate Loan Facility with Orion Energy Partners
US Nuclear Joins Fight Against Widespread Toxic PFAS Chemical Pollution in Our Air and Water
Energy 

US Nuclear Joins Fight Against Widespread Toxic PFAS Chemical Pollution in Our Air and Water

Jesse Knittel Comments Off on US Nuclear Joins Fight Against Widespread Toxic PFAS Chemical Pollution in Our Air and Water

Mining

Amex Drills 41.30 g/t Gold over 4.10 m including 202.81 g/t Au over 0.80 m in New Emerging Upper Gratien Zone, Perron Project
Mining 

Amex Drills 41.30 g/t Gold over 4.10 m including 202.81 g/t Au over 0.80 m in New Emerging Upper Gratien Zone, Perron Project

Jesse Knittel Comments Off on Amex Drills 41.30 g/t Gold over 4.10 m including 202.81 g/t Au over 0.80 m in New Emerging Upper Gratien Zone, Perron Project

Shallow intercept of up to 41.30 g/t Au over 4.1 m including 202.81 g/t Au over 0.8 m in Upper

Calibre Mining Announces a 318% Increase in the Pavon Gold Project Indicated Resource to 230,000 ounces Grading 5.16 g/t Gold; Resource Expansion Drilling Planned for 2020
Mining 

Calibre Mining Announces a 318% Increase in the Pavon Gold Project Indicated Resource to 230,000 ounces Grading 5.16 g/t Gold; Resource Expansion Drilling Planned for 2020

Jesse Knittel Comments Off on Calibre Mining Announces a 318% Increase in the Pavon Gold Project Indicated Resource to 230,000 ounces Grading 5.16 g/t Gold; Resource Expansion Drilling Planned for 2020
Anaconda Mining Discovers New Prospective Areas at its Tilt Cove Gold Project and Initiates Trenching and Drilling Program
Mining 

Anaconda Mining Discovers New Prospective Areas at its Tilt Cove Gold Project and Initiates Trenching and Drilling Program

Jesse Knittel Comments Off on Anaconda Mining Discovers New Prospective Areas at its Tilt Cove Gold Project and Initiates Trenching and Drilling Program
Nouveau Monde Provides an Update on Its Strategy to Produce Spherical Graphite Destined to Lithium-ion Batteries Market
Mining 

Nouveau Monde Provides an Update on Its Strategy to Produce Spherical Graphite Destined to Lithium-ion Batteries Market

Jesse Knittel Comments Off on Nouveau Monde Provides an Update on Its Strategy to Produce Spherical Graphite Destined to Lithium-ion Batteries Market

Biotech

BioLargo’s CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide Through Third-Party Lab Testing
BioTech 

BioLargo’s CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide Through Third-Party Lab Testing

Jesse Knittel Comments Off on BioLargo’s CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide Through Third-Party Lab Testing

Westminster, CA, Dec. 10, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioLargo, Inc. (OTCQB:BLGO) (“the Company”), developer of sustainable products

ProMIS Neurosciences’ Alzheimer’s disease program takes on renewed significance following positive aducanumab news
BioTech 

ProMIS Neurosciences’ Alzheimer’s disease program takes on renewed significance following positive aducanumab news

Jesse Knittel Comments Off on ProMIS Neurosciences’ Alzheimer’s disease program takes on renewed significance following positive aducanumab news
American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)
BioTech 

American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)

Jesse Knittel Comments Off on American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)
Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%
BioTech 

Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%

Jesse Knittel Comments Off on Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%